GENTAMICIN(E)
BAXTER CORPORATION
Quick answers
Is there a shortage of GENTAMICIN(E) in Canada?
No. There is no current shortage of GENTAMICIN(E) 1.6MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
GENTAMICIN
PHARMA STULLN INC.
CIDOMYCIN INJ 40MG/ML
ROUSSEL CANADA INC.
GARAMYCIN OPHTHALMIC DROPS 0.3%
MERCK CANADA INC
CIDOMYCIN INJ PEDIATRIC 10MG
ROUSSEL CANADA INC.
RATIO-GENTAMICIN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
GARAMYCIN ONT 0.1%
SCHERING-PLOUGH CANADA INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
GENTAMICIN(E) SULFATE
GENTAMICIN(E) SULFATE: Solution bags may be leaking in affected lots.
Highest health risk
Possible match — not confirmed
Gentamicin(E) Sulfate
Gentamicin(E) Sulfate: Solution bags may be leaking in affected lots.
Highest health risk
Possible match — not confirmed
DIN
02082152
Strength
1.6MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160